Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · Real-Time Price · USD

4.400

-0.040 (-0.90%)

At close: Apr 28, 2026, 4:00 PM EDT

4.420

+0.020 (0.45%)

After-hours: Apr 28, 2026, 6:47 PM EDT

Larimar Therapeutics Market Cap

Larimar Therapeutics has a market cap or net worth of $457.08 million as of April 28, 2026. Its market cap has increased by 301.06% in one year.

Market Cap

457.08M

Enterprise Value

322.22M

1-Year Change

301.06%

Ranking

#3134

Market Cap Chart

Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $457.08M, an increase of 303.14%. That is a compound annual growth rate of 26.58%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	461.24M	41.44%
Dec 31, 2025	326.10M	32.06%
Dec 31, 2024	246.93M	23.61%
Dec 29, 2023	199.77M	11.79%
Dec 30, 2022	178.70M	-6.49%
Dec 31, 2021	191.10M	-41.88%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
4D Molecular Therapeutics	479.88M
Candel Therapeutics	476.11M
Armata Pharmaceuticals	473.30M
Prelude Therapeutics	472.60M
Valneva SE	470.89M
Aura Biosciences	466.73M
Contineum Therapeutics	463.34M
Ginkgo Bioworks Holdings	458.09M

Market Cap Rankings